Pharmacoethnicity of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1038/s41598-021-99647-5
Published Online: 2021-10-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Yoon Suk
Lee, Jong-chan
Kim, Jae-Hyeong
Kim, Jaihwan
Hwang, Jin-Hyeok
Text and Data Mining valid from 2021-10-11
Version of Record valid from 2021-10-11
Article History
Received: 6 March 2021
Accepted: 2 September 2021
First Online: 11 October 2021
Competing interests
: The authors declare no competing interests.